Skip to main content

Ambiguous Genitalia

  • Chapter
  • First Online:
Endocrinology and Diabetes

Abstract

Disturbance of both the sex determination and differentiation occurs when the genotype (usually but not always 46XX or 46XY) is a variant of sexual phenotype, either partial or complete. Ambiguous genitalia describe a type of disorder of sexual development (DSD) in which the external phenotype is sufficiently abnormal to cause uncertainty regarding the sex of the child.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ahmed SF, Hughes IA. The genetics of male under masculinization. Clin Endocrinol (Oxf). 2002;56(1):1–18.

    Article  CAS  Google Scholar 

  2. Gardner DG, Shoback D. Greenpan’s basic & clinical endocrinology. Chapter 15, disorders of sexual determination & differentiation. 8th ed. New York, NY: The McGraw–Hill Companies, Inc.; 2007. p. 562–610.

    Google Scholar 

  3. Kronemberg HM, Melmed S, Polonsky KS, Larsen PR. William’s textbook of endocrinology. Chapter 22, Disorders of sex development. 11th ed. Philadelphia, PA: Saunders Elsevier; 2008. p. 783–848.

    Google Scholar 

  4. Lee P, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. International consensus conference on intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Pediatrics. 2006;118(2):e488–500.

    Article  PubMed  Google Scholar 

  5. Houk CP, Levitsky L. Evaluation of the infant with ambiguous genitalia. In: Basow DS, editor. Waltham, MA: UpToDate, Inc. www.uptodate.com

  6. Callegari C, Everett S, Ross M, Brasel JA. Anogenital ratio: measure of fetal virilization in premature and full-term newborn infants. J Pediatr. 1987 Aug;111(2):240–3.

    Article  PubMed  CAS  Google Scholar 

  7. Rey RA, Belville C, Nihoul-Fékété C, Michel-Calemard L, Forest MG, Lahlou N, et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. J Clin Endocrinol Metab. 1999 Feb;84(2):627–31.

    Article  PubMed  CAS  Google Scholar 

  8. Ahmed SF, Rodie M. Investigation and initial management of ambiguous genitalia. Best Pract Res Clin Endocrinol Metab. 2010 Apr;24(2):197–218.

    Article  PubMed  Google Scholar 

  9. Chavhan GB, Parra DA, Oudjhane K, Miller SF, Babyn PS, Pippi Salle FL. Imaging of ambiguous genitalia: classification and diagnostic approach. Radiographics. 2008;28(7):1891–904.

    Article  PubMed  Google Scholar 

  10. Mansour SM, Hamed ST, Adel L, Kamal RM, Ahmed DM. Does MRI add to ultrasound in the assessment of disorders of sex development? Eur J Radiol. 2012;81(9):2403–10.

    Article  PubMed  CAS  Google Scholar 

  11. Murphy C, Allen L, Jamieson MA. Ambiguous genitalia in newborn: an overview and teaching tool. J Pediatr Adolesc Gynecol. 2011;24(5):236–50.

    Article  PubMed  Google Scholar 

  12. Hughes IA, Houk C, Ahmed SF, LWPES Consensus Group, ESPE Consensus Group. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91(7):554–63.

    Article  PubMed  CAS  Google Scholar 

  13. Hughes IA. Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metab. 2008;22:119–34.

    Article  PubMed  Google Scholar 

  14. Isidor B, Capito C, Paris F, Baron S, Corradini N, Cabaret B, Leclair MD, Giraud M, Martin-Coignard D, David A, Sultan C, Le Caignec C. Familial frameshift SRY mutation inherited from a mosaic father with testicular dysgenesis syndrome. J Clin Endocrinol Metab. 2009;94(9):3467–71.

    Article  PubMed  CAS  Google Scholar 

  15. Paliwal P, Sharma A, Birla S, Kriplani A, Khadgawat R, Sharma A. Identification of novel SRY mutations and SF1 (NR5A1) changes in patients with pure gonadal dysgenesis and 46,XY karyotype. Mol Hum Reprod. 2011;17(6):372–8.

    Article  PubMed  CAS  Google Scholar 

  16. Ocal G, Berberoğlu M, Sıklar Z, Ruhi HI, Tükün A, Camtosun E, Erdeve SS, Hacıhamdioğlu B, Fitöz S. The clinical and genetic heterogeneity of mixed gonadal dysgenesis: does “disorders of sexual development (DSD)” classification based on new Chicago consensus cover all sex chromosome DSD? Eur J Pediatr. 2012;171:1497–502.

    Article  PubMed  Google Scholar 

  17. Velasco G, Savarese V, Sandorfi N, Jimenez SA, Jabbour S. 46, XX SRY-positive male syndrome presenting with primary hypogonadism in the setting of scleroderm. Endocr Pract. 2011;17(1):95–8.

    Article  PubMed  Google Scholar 

  18. Cox JJ, Willatt L, Homfray T, Woods CG. A SOX9 duplication and familial 46, XX developmental testicular disorder. N Engl J Med. 2011;364(1):91–3.

    Article  PubMed  CAS  Google Scholar 

  19. Hughes I. How should we classify intersex disorders? J Pediatr Urol. 2010;6(5):447–8.

    Article  PubMed  Google Scholar 

  20. Mendonca BB, Domenice S, Arnhold IJP, Costa EM. 46, XY disorders of sex development (DSD). Clin Endocrinol (Oxf). 2009;70(2):173–87.

    CAS  Google Scholar 

  21. Auchus R, Chang AY. 46, XX DSD: the masculinised female. Best Pract Res Clin Endocrinol Metab. 2010;24(2):219–42.

    Article  PubMed  Google Scholar 

  22. Nimkarn S, Lin-Su K, New MI. Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia. Pediatr Clin North Am. 2011;58(5):1281–300.

    Article  PubMed  Google Scholar 

  23. Lekarev O, Parsa A, Nimkarn S, Lin-Su K, New MI. Chapter 8, Congenital adrenal hyperplasia. Endotext.org. Updated 5 Nov 2010. www.endotext.org

  24. Mendonca BB, Costa EMF, Belgorosky A, Rivarola MA, Domenice S. 46, XY DSD due to impaired androgen production. Best Pract Res Clin Endocrinol Metab. 2010;24(2):243–62.

    Article  PubMed  CAS  Google Scholar 

  25. Walter KN, Kienzle FB, Frankenschmidt A, Hiort O, Wudy SA, van der Werf-Grohmann N, Superti-Furga A, Schwab KO. Difficulties in diagnosis and treatment of 5alpha-reductase type 2 deficiency in a newborn with 46,XY DSD. Horm Res Paediatr. 2010;74(1):67–71.

    Article  PubMed  CAS  Google Scholar 

  26. Werner R, Grötsch H, Hiort O. 46, XY disorders of sex development-the undermasculinised male with disorders of androgen action. Best Pract Res Clin Endocrinol Metab. 2010;24(2):263–77.

    Article  PubMed  CAS  Google Scholar 

  27. Abduljabbar M, Taheini K, Picard JY, Cate RL, Josso N. Mutations of the AMH type II receptor in two extended families with persistent Mullerian duct syndrome: lack of phenotype/genotype correlation. Horm Res Paediatr. 2012;77(5):291–7.

    Article  PubMed  CAS  Google Scholar 

  28. Hughes IA, Nihoul-Fékété C, Thomas B, Cohen-Kettenis PT. Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development. Best Pract Res Clin Endocrinol Metab. 2007;21(3):351–65.

    Article  PubMed  Google Scholar 

  29. Moran ME, Karkazis K. Developing a multidisciplinary team for disorders of sex development: planning implementation and operation tools for care providers. Adv Urol. 2012;2012:604135.

    Article  PubMed  Google Scholar 

  30. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, Wuite PC, Endocrine Society. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(9):4133–60.

    Article  PubMed  CAS  Google Scholar 

  31. Merke DP, Cho D, Calis KA, Keil MF, Chrousos GP. Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2001;86(1):441–5.

    Article  PubMed  CAS  Google Scholar 

  32. Verma S, Vanryzin C, Sinaii N, Kim MS, Nieman LK, Ravindran S, Calis KA, Arlt W, Ross RJ, Merke DP. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia. Clin Endocrinol (Oxf). 2010;72(4):441–7.

    Article  CAS  Google Scholar 

  33. Bryan SM, Honour JW, Hindmarsh PC. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion. J Clin Endocrinol Metab. 2009;94(9):3477–80.

    Article  PubMed  CAS  Google Scholar 

  34. Cheng TQ, Speiser PW. Treatment outcomes in congenital adrenal hyperplasia. Adv Pediatr. 2012;59(1):269–81.

    Article  PubMed  Google Scholar 

  35. Caldato MCF, Fernandes VT, Kater CE. One-year clinical evaluation of single morning dose prednisolone therapy for 21-hydroxylase deficiency. Arq Bras Endocrinol Metabol. 2004;48(5):705–12.

    Article  PubMed  Google Scholar 

  36. Sperling MA. Pediatric endocrinology. Ambiguous genitalia. 3rd ed. Philadelphia, PA: Saunders Elsevier; 2008. p. 127–64.

    Google Scholar 

  37. Lee PA, Houk CP. Disorders of sexual differentiation in the adolescent. Ann N Y Acad Sci. 2008;1135:67–75.

    Article  PubMed  Google Scholar 

  38. Viswanathan V, Eugster E. Etiology and treatment of hypogonadism in adolescent. Endocrinol Metab Clin North Am. 2009;38(4):719–38.

    Article  PubMed  CAS  Google Scholar 

  39. Bertelloni S, Baroncelli GI, Garofalo P, Cianfarani S. Androgen therapy in hypogonadal adolescent males. Horm Res Paediatr. 2010;74:292–6.

    Article  PubMed  CAS  Google Scholar 

  40. Mieszczak J, Houk CP, Lee PA. Assignment of the sex of rearing in the neonate with a disorder of sex development. Curr Opin Pediatr. 2009;21(4):541–7.

    Article  PubMed  Google Scholar 

  41. Houk CP, Lee PA. Gender assignment in DSD infants with male genitalia. J Clin Endocrinol Metab. 2010;95(10):4501–8.

    Article  PubMed  CAS  Google Scholar 

  42. Mazur T. Gender dysphoria and gender change in androgen insensitivity or micropenis. Arch Sex Behav. 2005;34:411–21.

    Article  PubMed  Google Scholar 

  43. Matsubara K, Iwamoto H, Yoshida A, Ogata T. Semen analysis and successful paternity by intracytoplasmic sperm injection in a man with steroid 5α-reductase-2 deficiency. Fertil Steril. 2010;94(7):2770.e7–10.

    Article  Google Scholar 

  44. Ciaccio M, Costanzo M, Guercio G, De Dona V, Marino R, Ramirez PC, Galeano J, Warman DM, Berensztein E, Saraco N, Baquedano MS, Chaler E, Maceiras M, Lazzatti JM, Rivarola MA, Belgorosky A. Preserved fertility in a patient with a 46, XY disorder of sex development due to a new heterozygous mutation in the NR5A1/SF-1 gene: evidence of 46, XY and 46, XX gonadal dysgenesis phenotype variability in multiple members of an affected kindred. Horm Res Paediatr. 2012;78:119–26.

    Article  PubMed  CAS  Google Scholar 

  45. Cohen-Kettenis PT. Gender change in 46, XY persons with 5α-reductase-2 deficiency and 17β-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav. 2005;34(4):399–410.

    Article  PubMed  Google Scholar 

  46. Roamo RLP, Pippi Salle JL, Wherrett DK. Update on the management of disorders of sex development. Pediatr Clin North Am. 2012;59(4):853–69.

    Article  Google Scholar 

  47. Hurt WG, Bodurtha JN, McCall JB, et al. Seminoma in pubertal patient with androgen insensitivity syndrome. Am J Obstet Gynecol. 1989;161(3):530–1.

    Article  PubMed  CAS  Google Scholar 

  48. Warne GL, Mann A. Ethical and legal aspects of management for disorders of sex development. J Paediatr Child Health. 2011;47(9):661–3.

    Article  PubMed  Google Scholar 

  49. Houk CP, Lee PA. Update on disorders of sex development. Curr Opin Endocrinol Diabetes Obes. 2012;19(1):28–32.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marilia Martins Guimarães M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

de Souza, M.A.R., Beserra, I.C.R., Guimarães, M.M. (2014). Ambiguous Genitalia. In: Bandeira, F., Gharib, H., Golbert, A., Griz, L., Faria, M. (eds) Endocrinology and Diabetes. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8684-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8684-8_19

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8683-1

  • Online ISBN: 978-1-4614-8684-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics